348 related articles for article (PubMed ID: 31548394)
1. Phosphorylation of DEPDC5, a component of the GATOR1 complex, releases inhibition of mTORC1 and promotes tumor growth.
Padi SKR; Singh N; Bearss JJ; Olive V; Song JH; Cardó-Vila M; Kraft AS; Okumura K
Proc Natl Acad Sci U S A; 2019 Oct; 116(41):20505-20510. PubMed ID: 31548394
[TBL] [Abstract][Full Text] [Related]
2. Skeletal muscle-specific knockout of DEP domain containing 5 protein increases mTORC1 signaling, muscle cell hypertrophy, and mitochondrial respiration.
Graber TG; Fry CS; Brightwell CR; Moro T; Maroto R; Bhattarai N; Porter C; Wakamiya M; Rasmussen BB
J Biol Chem; 2019 Mar; 294(11):4091-4102. PubMed ID: 30635399
[TBL] [Abstract][Full Text] [Related]
3. GATOR1 Mutations Impair PI3 Kinase-Dependent Growth Factor Signaling Regulation of mTORC1.
Muller M; Bélanger J; Hadj-Aissa I; Zhang C; Sephton CF; Dutchak PA
Int J Mol Sci; 2024 Feb; 25(4):. PubMed ID: 38396745
[TBL] [Abstract][Full Text] [Related]
4. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
5. A Tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1.
Bar-Peled L; Chantranupong L; Cherniack AD; Chen WW; Ottina KA; Grabiner BC; Spear ED; Carter SL; Meyerson M; Sabatini DM
Science; 2013 May; 340(6136):1100-6. PubMed ID: 23723238
[TBL] [Abstract][Full Text] [Related]
6. Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma.
Schatz JH; Oricchio E; Wolfe AL; Jiang M; Linkov I; Maragulia J; Shi W; Zhang Z; Rajasekhar VK; Pagano NC; Porco JA; Teruya-Feldstein J; Rosen N; Zelenetz AD; Pelletier J; Wendel HG
J Exp Med; 2011 Aug; 208(9):1799-807. PubMed ID: 21859846
[TBL] [Abstract][Full Text] [Related]
7. SZT2 dictates GATOR control of mTORC1 signalling.
Peng M; Yin N; Li MO
Nature; 2017 Mar; 543(7645):433-437. PubMed ID: 28199315
[TBL] [Abstract][Full Text] [Related]
8. Architecture of the human GATOR1 and GATOR1-Rag GTPases complexes.
Shen K; Huang RK; Brignole EJ; Condon KJ; Valenstein ML; Chantranupong L; Bomaliyamu A; Choe A; Hong C; Yu Z; Sabatini DM
Nature; 2018 Apr; 556(7699):64-69. PubMed ID: 29590090
[TBL] [Abstract][Full Text] [Related]
9. Functional screening of GATOR1 complex variants reveals a role for mTORC1 deregulation in FCD and focal epilepsy.
Dawson RE; Nieto Guil AF; Robertson LJ; Piltz SG; Hughes JN; Thomas PQ
Neurobiol Dis; 2020 Feb; 134():104640. PubMed ID: 31639411
[TBL] [Abstract][Full Text] [Related]
10. KLHL22 activates amino-acid-dependent mTORC1 signalling to promote tumorigenesis and ageing.
Chen J; Ou Y; Yang Y; Li W; Xu Y; Xie Y; Liu Y
Nature; 2018 May; 557(7706):585-589. PubMed ID: 29769719
[TBL] [Abstract][Full Text] [Related]
11. Knockout of the epilepsy gene Depdc5 in mice causes severe embryonic dysmorphology with hyperactivity of mTORC1 signalling.
Hughes J; Dawson R; Tea M; McAninch D; Piltz S; Jackson D; Stewart L; Ricos MG; Dibbens LM; Harvey NL; Thomas P
Sci Rep; 2017 Oct; 7(1):12618. PubMed ID: 28974734
[TBL] [Abstract][Full Text] [Related]
12. Insulin receptor substrate 1 is a substrate of the Pim protein kinases.
Song JH; Padi SK; Luevano LA; Minden MD; DeAngelo DJ; Hardiman G; Ball LE; Warfel NA; Kraft AS
Oncotarget; 2016 Apr; 7(15):20152-65. PubMed ID: 26956053
[TBL] [Abstract][Full Text] [Related]
13. Depdc5 deficiency exacerbates alcohol-induced hepatic steatosis via suppression of PPARα pathway.
Xu L; Zhang X; Xin Y; Ma J; Yang C; Zhang X; Hou G; Dong XC; Sun Z; Xiong X; Cao X
Cell Death Dis; 2021 Jul; 12(7):710. PubMed ID: 34267188
[TBL] [Abstract][Full Text] [Related]
14. PIM activity in tumours: A key node of therapy resistance.
Rebello RJ; Huglo AV; Furic L
Adv Biol Regul; 2018 Jan; 67():163-169. PubMed ID: 29111105
[TBL] [Abstract][Full Text] [Related]
15. DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.
Iffland PH; Baybis M; Barnes AE; Leventer RJ; Lockhart PJ; Crino PB
Neurobiol Dis; 2018 Jun; 114():184-193. PubMed ID: 29481864
[TBL] [Abstract][Full Text] [Related]
16. Arg-78 of Nprl2 catalyzes GATOR1-stimulated GTP hydrolysis by the Rag GTPases.
Shen K; Valenstein ML; Gu X; Sabatini DM
J Biol Chem; 2019 Feb; 294(8):2970-2975. PubMed ID: 30651352
[TBL] [Abstract][Full Text] [Related]
17. Adipocyte-specific deletion of Depdc5 exacerbates insulin resistance and adipose tissue inflammation in mice.
Zhang J; Shi Y; Yang C; Sun B; Ma H; Huang R; Li Z; Wang M; Wang Q; Ma J; Xiong X
Biochem Biophys Res Commun; 2021 Sep; 569():118-124. PubMed ID: 34243067
[TBL] [Abstract][Full Text] [Related]
18. DEPDC5-dependent mTORC1 signaling mechanisms are critical for the anti-seizure effects of acute fasting.
Yuskaitis CJ; Modasia JB; Schrötter S; Rossitto LA; Groff KJ; Morici C; Mithal DS; Chakrabarty RP; Chandel NS; Manning BD; Sahin M
Cell Rep; 2022 Aug; 40(9):111278. PubMed ID: 36044864
[TBL] [Abstract][Full Text] [Related]
19. PIM-1-specific mAb suppresses human and mouse tumor growth by decreasing PIM-1 levels, reducing Akt phosphorylation, and activating apoptosis.
Hu XF; Li J; Vandervalk S; Wang Z; Magnuson NS; Xing PX
J Clin Invest; 2009 Feb; 119(2):362-75. PubMed ID: 19147983
[TBL] [Abstract][Full Text] [Related]
20. PIM1 protein kinase regulates PRAS40 phosphorylation and mTOR activity in FDCP1 cells.
Zhang F; Beharry ZM; Harris TE; Lilly MB; Smith CD; Mahajan S; Kraft AS
Cancer Biol Ther; 2009 May; 8(9):846-53. PubMed ID: 19276681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
